NCT07606066招募中不适用
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- AstraZeneca
- 入组人数
- 2,150
- 试验地点
- 89
研究概览
简要总结
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants must be ≥ 18 years of age at the time of signing the ICF.
- •Patients with a diagnosis of T2DM, test- or documentation-confirmed as per World
- •Health Organization or local diagnostic standards, inadequately managed with:
- •Lifestyle management alone, AND/OR
- •A stable dose of background glucose-lowering medication(s) for T2DM (As specified in the Protocol) for at least 45 days prior to signing the ICF.
- •Expresses interest in participating in an ongoing or future T2DM clinical study, is motivated and willing to make themselves available for the duration of the study, and is able to follow study procedures as required.
- •Provision of signed and dated written informed consent (As specified in the Protocol) before any study-specific procedures, sampling, or analysis.
排除标准
- •Current or planned use of GLP-1 RAs prohibited in ongoing or future T2DM studies evaluating the efficacy and safety of investigational GLP-1 RAs (As specified in the Protocol).
- •Diagnosed with Type 1 diabetes mellitus.
- •Known pregnancy at the time of visit or having the intention to become pregnant.
研究组 & 干预措施
Participants with Type 2 Diabetes
Participants with Type 2 Diabetes
干预措施: Procedure: assessment (Other)
研究者
研究点 (89)
Loading locations...
相似试验
尚未招募
不适用
To study the effect of Tuberculosis in Patients of Diabetes MellitusCTRI/2025/03/081507Dr DY Patil Medical College and Hospital60
已完成
不适用
Evaluating Understanding of Type 2 Diabetes Mellitus and Correlation with HbA1C and the 6-minute walk distance test: An Observational StudyCTRI/2025/06/088560MAEERs physiotherapy college194
已完成
3 期
Study to Assess the Effectiveness and Safety of Sairub Heal Diaba Care, Sairub Diaba Neuro Pain Oil, and Sairub Heal Pain Balm in Treating Nerve Pain in Type 2 Diabetic Patients.CTRI/2025/01/079258Saisa Medi LLP100
招募中
4 期
Interventional, Single arm, open-label study to evaluate the efficacy and safety of Imeglimin using Continuous Glucose Monitoring (CGM) in Type 2 Diabetes Mellitus (T2DM) patientsDiabetesCTRI/2025/02/079966Dr Unnikrishnan Ambika Gopalakrishnan30
尚未招募
不适用
Study on urine infections in patients taking SGLT2 medicine for diabetes.CTRI/2026/02/103847L M College of Pharmacy100